Dr Antal Hajos appointed as MD, CEO Europe at Ecron Acunova

Bangalore/ Frankfurt, Apr 1 (ANI/Business Wire India): D A Prasanna, Founder of Ecron Acunova, based out of Germany, India and US, is pleased to announce the appointment of Dr. Antal K. Hajos as Managing Director of Ecron Acunova and CEO Europe.

In his new role, Dr Hajos will have overall responsibility for all business, strategic and operational aspects of the European operations. Ecron Acunova GmbH, located in Frankfurt, Germany, is the European Headquarter of the Group.

Dr Hajos has more than 15 years experience in the Pharmaceutical and CRO industry. Prior to joining the company last year, Dr Hajos was Director - Global Clinical Operations with Altana Pharma, headquartered in Germany, and later CEO of Altana/Nycomed's R and D centre and Indian affiliate in Mumbai.

Dr Hajos holds a PhD in Biochemistry from Lousiana State University, Baton Rouge, USA. He succeeds Dr Klaus D Wiedey, founder and CEO of ECRON, who developed and led the organization. Dr Wiedey will further act as an advisor to the company.

On his new appointment, Dr Hajos said, "Ecron Acunova has in the past 18 months been able to create a unique platform of East and West synergizing on quality delivery and customer responsiveness. I have been impressed by the outstanding talent we have in the organization and the progress made to leverage the opportunities for international delivery out of our sites to the benefit of our clients. I am convinced Ecron Acunova is becoming an important player in our industry, and I am excited to be part of that development."

Ecron Acunova represents the synergy of 22 years of European full-service CRO experience (ECRON) and the Indian CRO pioneer (Acunova) with privileged access to Asia's largest academic medical centre. With offices in Europe, Asia and USA, Ecron Acunova is able to translate the combination of cultures and capabilities into quality and speed at competitive costs. Ecron Acunova has vast therapeutic experience with a special focus on oncology, diagnostic imaging and respiratory areas.

Speaking on Dr Hajos' appointment, D A Prasanna said, "Ecron Acunova has a long reputation for quality CRO services in Europe. In the past 18 months, our service portfolio has grown to include Phase I, CDM, and central lab services in India. Ecron Acunova's geography to conduct trials has expanded to the US and Asia. Dr. Hajos brings rich experience of leveraging the service portfolio and geography for the benefit of European clients."

Our European offices are located in Germany (Frankfurt/Main, Constance, Berlin), the Czech Republic (Prague), Poland (Warsaw), Ukraine (Kiev), United Kingdom (London), Italy (Florence) and Spain (Barcelona). Further countries are covered under long-lasting partnerships. (ANI)